Teladoc Health (Teladoc Health) Total Stockholders Equity : $2,326 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Teladoc Health Total Stockholders Equity?

Teladoc Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,326 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Teladoc Health's Book Value per Share for the quarter that ended in Dec. 2023 was $13.96. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Teladoc Health's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.68.

Teladoc Health Total Stockholders Equity Historical Data

The historical data trend for Teladoc Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health Total Stockholders Equity Chart

Teladoc Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,014.03

15,883.80

16,045.76

2,307.75

2,326.07

Teladoc Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															2,307.75	2,291.23	2,295.14	2,294.05	2,326.07

Teladoc Health (NYSE:TDOC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Teladoc Health's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2326.073	-	0)	/	166.658
	=	13.96

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Teladoc Health's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10.752	+	1581.525)	/	2326.073
	=	0.68

Teladoc Health Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Teladoc Health's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Teladoc Health (Teladoc Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TDOC:Mexico 4LL:Germany T2DH34:Brazil

Address

2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577

Website

https://www.teladochealth.com

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Executives

Daniel Trencher	officer: SVP Corporate Strategy	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella	officer: Chief Medical Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic	director, officer: President & CEO
Andrew Turitz	officer: SVP - Business Development	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete	officer: Chief Marketing Officer	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort	officer: Chief Legal Officer, Secretary	485 MADISON AVENUE, NEW YORK NY 10022
Mala Murthy	officer: Chief Financial Officer	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Richard J Napolitano	officer: Chief Accounting Officer	MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Arnnon Geshuri	officer: Chief Human Resources Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser	officer: PRESIDENT, ENTERPRISE GROWTH	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Michael Willem Waters	officer: CHIEF OPERATING OFFICER	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Jason Eric Evans	director	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Claus Torp Jensen	officer: Chief Innovation Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Sandra L Fenwick	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577